UTime Ltd

UTime Ltd. engages in the operation of designing, manufacturing, and marketing mobile communication devices, and selling a variety of related accessories. The firm is also involved in providing mobile devices to consumers and help individuals from established markets in having better access to updated mobile technology. The company was founded by Min Fei Bao, Jun Lin Zhou, and Bo Tang in June 2008 and is headquartered in Shenzhen, China.

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) --  UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that on October 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it has entered into a securities purchase agreement with certain accredited investor to sell $5 million of its ordinary shares in a registered direct offering.

UTime Limited Announces Pricing of $5 Million Registered Direct Offering

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), at a ratio of 1-for-25, to be effective on or around the open of trading on September 11, 2024.

UTime Limited Announces 1-For-25 Reverse Share Split

SHENZHEN, China , Aug. 29, 2024 /PRNewswire/ --  Dear Investors, Analysts and Media: Recently, UTime Ltd ("UTime") has experienced a period of unusual share price volatility in the capital markets. As a responsible company, we understand the concerns of market participants about such situations and believe that it is necessary to provide the public with transparent and formalized information in this regard.

Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

SHENZHEN, China , Aug. 29, 2024 /PRNewswire/ -- UTime Limited (NASDAQ:  WTO ) ("UTime" or the "Company"), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive financial and legal due diligence on Bowen Therapeutics Inc ("Bowen Therapeutics"), which it intends to acquire. The move marks an important step in UTime's expansion of its presence in the field of innovative medical products, with the aim of strengthening its market position and advancing the future of medical technology.

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

SHENZHEN, China , Aug. 28, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for the acquisition of the Bowen Therapeutics laboratory at UMASS Medical School. This strategic move not only marks UTime's in-depth expansion in the global vaccine market, but also provides strong support for the registration of the relevant vaccine through the U.S. Food and Drug Administration (the "FDA").

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

SHENZHEN, China , Aug. 26, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is excited to announce its collaboration on Circul VS, a core continuous blood pressure measurement technology system developed in partnership with strategic partner, Dr. Ehud Baron. Designed to offer patients an accurate and user-friendly continuous blood pressure monitoring solution, Circul VS facilitates early detection and long-term management, helping to reduce the risks associated with cardiovascular and cerebrovascular conditions.

About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron

SHENZHEN, China , Aug. 23, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its plans to participate in a series of internationally recognized medical fairs and medical conferences. These forthcoming events will provide a valuable opportunity for UTime to showcase its latest achievements in medical devices and solutions and to enhance its communication and partnerships within the global medical industry.

UTime Limited to Participate in International Medical Fairs and Medical Conferences

SHENZHEN, China , Aug. 21, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recognizing the growing value and potential of smart health technologies, UTime is committing significant investments to expand its smart medical wearable products business.

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

SHENZHEN, China , Aug. 19, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular disease management.

UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company's ordinary shares to maintain a minimum bid price of $1.00 per share.

UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: UTME), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, today announced that on February 28, 2024, the Company received a written notification from the Nasdaq's Listing Qualifications Department, granting the Company another 180 calendar days extension, or until August 26, 2024, to regain compliance with Nasdaq's minimum bid price requirement.

UTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

SHENZHEN, China, Sept. 15, 2023 (GLOBE NEWSWIRE) -- United Time Technology Co. Ltd, an entity controlled via contractual agreement by UTime Ltd. (NASDAQ:WTO; the "Company" or “WTO”) signed a strategic partnership agreement on September 12, 2023 to design, assemble and supply up to 10,000 new smart EV chargers to Shenzhen Jiuzi XinNeng Holding Group Co., Ltd. (“Jiuzi”), an indirect subsidiary of Jiuzi Holdings, Inc. (NASDAQ: JZXN) from 2024 to 2027. The parties aim to deploy the chargers to provide more convenient and efficient charging solutions for electric vehicle users in third and fourth-tier cities in China. This cooperation is expected to leverage the advantages of both parties in technology, service and marketing to inject new impetus into the sustainable development of the electric vehicle industry chain and create greater value for investors, partners and customers.

UTime Ltd. Announces Strategic Partnership Agreement to Supply up to 10,000 Smart Electric Vehicle (EV) Chargers to Subsidiary of Jiuzi Holdings Inc. (NASDAQ: JZXN)

SHENZHEN, China, Aug. 28, 2023 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ: UTME; the "Company" or “UTME”) announced that the Company will be changing its ticker symbol from "UTME" to "WTO”. Effective on Tuesday September 5, 2023, the Company's ordinary shares will trade on Nasdaq under the new symbol “WTO”.

News for UTime Ltd Stock (WTO)